You are here: Industry Insights > Cancer Research UK

News List

Hummingbird Bioscience Announces First Patient Dosed in Phase 1 Clinical Trial of HMBD-001 in Advanced HER3-Expressing Solid Malignancies prnasia
December 07, 2021
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, and Cancer Research UK...
Achilles' US IPO closed with proceeds of $175m pharmatimes
April 09, 2021
Cancer Research UK spinout Achilles Therapeutics has closed its Initial Public Offering in the US bagging gross proceeds of $175.5 million.
CR UK calls on Scottish gov to 'urgently' restart cancer trials pharmatimes
June 30, 2020
As of this morning – Tuesday June 30 – the current recorded case count for COVID-19 (coronavirus) in the UK has reached 311,965 with 43,575 deaths.
Cancer Research UK to fund Bicycle’s immuno-oncology candidate pharmaceutical-technology
January 09, 2020
Cancer Research UK has agreed to fund exploratory development of Bicycle Therapeutics’ immuno-oncology candidate BT7401.
Hummingbird and Cancer Research UK to develop antibody drug HMBD-001 pharmaceutical-technology
August 09, 2019
Biotechnology company Hummingbird Bioscience and Cancer Research UK have collaborated to develop the former’s anti-HER3 clinical grade antibody drug, HMBD-001 to treat people with HER3 driven cancer.
Cancer Research UK forms alliance for oncology medicines pharmaceutical-technology
July 03, 2019
Cancer Research UK has collaborated with life sciences venture capital firm SV Health Investors (SV) to support the development of cancer drugs.
Cancer immunotherapy alliance formed by CR UK, Lifearc and Ono Pharma Form pharmatimes
March 28, 2019
Cancer Research UK, LifeArc and Ono Pharmaceutical Co have collaborated to form a multi-million-pound drug discovery alliance.
Cancer Research UK to fund three international research projects pharmaceutical-technology
January 25, 2019
Cancer Research UK is set to fund three new international research projects focused on better understanding the microbiome in human bodies.....
New clinical trial reduces breast cancer radiotherapy side effects pharmatimes
December 24, 2018
A practice-changing new clinical trial has been found to reduce long-term radiotherapy side effects in women with breast cancer.
Mirati joins CR UK’s Stratified Medicine Programme pharmatimes
November 22, 2018
Mirati Therapeutics has joined Cancer Research UK’s Stratified Medicine Programme, bringing new investigational treatment options to eligible patients with advanced lung cancer.

Previous page 1 2 Next page